Multibic (Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc)

Sodium Hydrogen Carbonate acts as a buffering agent that neutralises excess hydrogen ions, correcting metabolic acidosis. Together with magnesium, potassium, sodium and calcium ions, it restores normal electrolyte concentrations and supports cellular function during dialysis.

The prescribed volume and rate of Multibic infusion are determined by the treating physician based on the patient’s weight, laboratory values and the specific dialysis protocol. Dosage is individualized and should follow the clinician’s orders.

Safety data for Multibic in pregnancy or lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by the prescribing healthcare professional.

To order Multibic, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Multibic offers a balanced electrolyte composition with sodium hydrogen carbonate for buffering, similar to other commercial dialysis fluids. Its specific ion concentrations may differ, providing clinicians flexibility to match patient needs, while maintaining regulatory compliance and GMP standards.

Multibic should be stored at 2‑8 °C, protected from light, and must not be frozen or shaken. Keep the solution in its original packaging until use and discard any product that appears discoloured or contaminated.

Multibic is supplied as a sterile solution for injection and is administered intravenously through the dialysis circuit. The infusion rate and total volume are set by the dialysis machine according to the prescribed treatment protocol.

Serious risks include severe electrolyte disturbances such as hyperkalemia or calcium overload, which can lead to cardiac arrhythmias, as well as rare anaphylactic reactions. Continuous monitoring of vital signs and laboratory parameters is essential during treatment.

Multibic should be avoided in patients with known hypersensitivity to any of its components, those with uncontrolled electrolyte imbalances that cannot be corrected, or individuals for whom rapid shifts in plasma osmolarity are contraindicated. Clinical judgment is required for each case.